Close Menu


Researchers saw a shift toward lower gut bifidobacterial levels and a dip in pro-inflammatory Th17 immune cells due to ketone bodies production.

Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines.

Profiling microbial communities in cervicovaginal samples from women carrying high-risk HPV strains, researchers found possible markers of pre-cancer progression.

The US Food and Drug Administration has issued a safety alert for fecal microbiota transplants as SARS-CoV-2 has been found in patients' stool.

Seeing the Tongue-ome

Researchers find through imaging that the tongue microbiome is highly structured, Science reports.

In PNAS this week: interactions of coronavirus' EndoU endoribonuclease enzyme, analysis of phylogenetic trees, and more.

In PLOS this week: yeast modeling of mutations found through MSKCC IMPACT, tumor features associated with presence of circulating DNA, and more.

Previous studies that detected the presence of the N6-methyladenine bacterial DNA modification in mammalian cells were most likely contaminated.

Tracing and Diving In

BBC News reports on a sequencing effort to track SARS-CoV-2 infections and uncover any co-infections.

Multi-omics approaches can give insight into the gut microbiome and more, but there are still challenges to address, speakers at the ABRF meeting said.


New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.